Clinical trials for long-term administration of sirolimus for lymphangioleiomyomatosis

Clinical trials for long-term administration of sirolimus for lymphangioleiomyomatosis - Long-term administration of sirolimus for lymphangioleiomyomatosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007387

Enrollment

Registered

2012-04-01

Start date

2012-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphangioleiomyomatosis

Interventions

sirolimus

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients with lymphangioleiomyomatosis

Exclusion criteria

Exclusion criteria: pregnancy

Design outcomes

Primary

Measure	Time frame
Symptoms, respiratory function, presence or absence of side effects after two years of administration	—

Countries

Japan

Contacts

Public Contactyoshihiro Nishimura

Kobe University Graduate School of Medicine Division of Respiratiry Medicine

nishiy@med.kobe-u.ac.jp078-382-5668

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026